Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Hiroyuki Sakamaki"'
Autor:
Hiroyuki Tsutsui, Hiroyuki Sakamaki, Shin‐ichi Momomura, Yasushi Sakata, Yutaro Kotobuki, Stephan Linden, Koki Idehara, Daisuke Nitta
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 261-270 (2024)
Abstract Aims Empagliflozin, a sodium‐glucose co‐transporter 2 inhibitor, was shown to be effective in patients with heart failure with preserved ejection fraction (HFpEF) in the EMPEROR‐Preserved trial. The present study aims to evaluate the c
Externí odkaz:
https://doaj.org/article/26482e2ac0aa4e53ad22a19d9a7b587c
Autor:
Shigeki Suzuki, Keisuke Asakura, Masayuki Okui, Naoko Izawa, Makoto Sawafuji, Hiroyuki Sakamaki, Takao Shigenobu, Atsushi Tajima, Naoyuki Oka, Kyohei Masai, Kaoru Kaseda, Tomoyuki Hishida, Hiroyuki Yasuda, Koichi Fukunaga, Hisao Asamura
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background The prevalence of salvage surgeries after drug therapy for non-small cell lung cancer (NSCLC) has risen, mainly due to recent progress in molecular-targeted drugs and immune checkpoint inhibitors for NSCLC. While the safety and ef
Externí odkaz:
https://doaj.org/article/bdc68d7712cc488895148fb85f4fe3b2
Autor:
Hiroyuki Tsutsui, Hiroyuki Sakamaki, Shin-ichi Momomura, Yasushi Sakata, Yutaro Kotobuki, Stephan Linden, Odette S. Reifsnider, Pal Rakonczai, Matthew Stargardter, Tatsunori Murata, Tetsuaki Hirase, Daisuke Nitta
Publikováno v:
Journal of Cardiology. 81:522-530
Autor:
Wentao Tang, Keigo Hanada, Yoshiharu Motoo, Hiroyuki Sakamaki, Takaaki Oda, Kazuyuki Furuta, Hikaru Abutani, Satoru Ito, Kiichiro Tsutani
Publikováno v:
Journal of Medical Economics. 26:614-626
Autor:
Takao Shigenobu, Takashi Ohtsuka, Ryutaro Hanawa, Hiroyuki Sakamaki, Akira Yoshizu, Atsushi Tajima
Publikováno v:
Annals of Thoracic & Cardiovascular Surgery; 2023, Vol. 29 Issue 6, p279-286, 8p
Autor:
Natsuki Ichihashi, Kosuke Kamikawabata, Kenzo Shibata, Kenta Murotani, Hiroyuki Sakamaki, Hiroyuki Kamei, Manako Hanya
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 47:688-700
Autor:
Hiroyuki Sakamaki, Kohei Hashimoto
Publikováno v:
JTCVS Techniques
Autor:
Hiroyuki Sakamaki, Katsura Tsukamoto, Motoaki Yoshino, Shinya Ohno, Yirong Chen, Naoki Matsumaru
Publikováno v:
Journal of Medical Economics. 24:266-278
The growing prevalence of Alzheimer's disease (AD) worldwide has sparked the implementation of national policies to support the growing burden among caregivers of AD/dementia patients. This study aims to quantify and compare the burden of AD/dementia
Autor:
Keigo Hanada, Tetsuaki Hirase, Hirotaka Watada, Tatsunori Murata, Daisuke Yabe, Tomoo Okamura, Fumiko Yamamoto, Hiroyuki Sakamaki
Publikováno v:
Diabetes Therapy
Introduction We evaluated the cost-effectiveness of linagliptin in Japan by estimating the lifetime outcome based on clinical event rates from the Asian subpopulation of the CARMELINA trial. In CARMELINA, linagliptin added to standard of care (SoC) v
Publikováno v:
Journal of Medical Economics. 23:429-441
Aims: Understanding the burden of cancer in Japan is becoming increasingly important to address the socio-economic consequences of the disease. This study broadly examined the cancer burden in term...